ArticleBMC gastroenterology2025
The ratio of omega-6 fatty acids to omega-3 fatty acids mediating the effect of gastroesophageal reflux disease on pancreatic cancer risk: a two-step mediation Mendelian randomisation study.
Article in BMC gastroenterology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
introductionPancreatic cancer (PC) is the third most common cause of cancer-related deaths worldwide, with the 5-year survival rate for patients with PC in developed countries being only 9-10%. Gastroesophageal reflux disease (GERD) is known to be a high-risk factor for several cancers. However, the relationship between GERD and PC remains controversial. Therefore, this study aimed to investigate the causal association between GERD and the risk of PC. Additionally, we sought to validate the role of omega-6/omega-3 polyunsaturated fatty acids (n-6/n-3 PUFA) as mediators in this pathway by calculating their mediating effect.
methodsFirst, a two-step, two-sample Mendelian randomisation (TSMR) framework was established to test the causal relationship between GERD and PC and to determine whether n-6/n-3 PUFA could act as a mediator of the causal pathway. Subsequently, using multivariate Mendelian randomisation (MVMR), the proportion of mediators mediated by n-6/n-3 PUFA was calculated using the product of coefficients approach.
resultsThe two-step TSMR results showed that GERD was positively associated with PC (n = 27 SNPs, OR 2.07 95% CI 1.27-3.39, P = 0.003 β = 0.72). Additionally, GERD was positively associated with n-6/n-3 PUFAs (n = 59 SNPs, OR 1.06, 95% CI 1.02-1.11 P = 0.001, β1 = 0.06), which are positively associated with PC (n = 28 SNPs, OR 1.23, 95% CI 1.04-1.46, P = 0.02, β = 0.20). The MRMV results demonstrated that after controlling for GERD, the n-6/n-3 PUFA had an impact on PC (n = 17 SNPs, se = 0.07, P = 0.004, β2 = 0.21). Furthermore, the causal effect of GERD on PC was partially mediated through the n-6/n-3 PUFA (n = 31 SNPs, se = 0.20, P = 0.03, β3 = 0.42) with a 2.9% mediating effect.
conclusionThis study provides insights into the pathological processes that link GERD to PC. In addition, it offers a novel approach to PC prevention and early detection. In clinical practice, early screening and drug usage control in patients with GERD must be prioritised. Furthermore, dietary supplementation with n-3 PUFAs and proper n-6 PUFA reduction may minimise the prevalence of PC.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.